Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer

10.3390/cancers12082092

Saved in:
Bibliographic Details
Main Authors: Kafka, M., Mayr, F., Temml, V., Möller, G., Adamski, J., Höfer, J., Schwaiger, S., Heidegger, I., Matuszczak, B., Schuster, D., Klocker, H., Bektic, J., Stuppner, H., Eder, I.E.
Other Authors: BIOCHEMISTRY
Format: Article
Published: MDPI AG 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/199759
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-199759
record_format dspace
spelling sg-nus-scholar.10635-1997592024-04-16T03:47:34Z Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer Kafka, M. Mayr, F. Temml, V. Möller, G. Adamski, J. Höfer, J. Schwaiger, S. Heidegger, I. Matuszczak, B. Schuster, D. Klocker, H. Bektic, J. Stuppner, H. Eder, I.E. BIOCHEMISTRY AR-V7 ARK1C3 Cancer-associated fibroblasts (CAFs) Enzalutamide resistance Prostate cancer Spheroid culture 10.3390/cancers12082092 Cancers 12 8 1-18 2021-08-27T04:23:25Z 2021-08-27T04:23:25Z 2020 Article Kafka, M., Mayr, F., Temml, V., Möller, G., Adamski, J., Höfer, J., Schwaiger, S., Heidegger, I., Matuszczak, B., Schuster, D., Klocker, H., Bektic, J., Stuppner, H., Eder, I.E. (2020). Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer. Cancers 12 (8) : 1-18. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers12082092 2072-6694 https://scholarbank.nus.edu.sg/handle/10635/199759 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ MDPI AG Scopus OA2020
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic AR-V7
ARK1C3
Cancer-associated fibroblasts (CAFs)
Enzalutamide resistance
Prostate cancer
Spheroid culture
spellingShingle AR-V7
ARK1C3
Cancer-associated fibroblasts (CAFs)
Enzalutamide resistance
Prostate cancer
Spheroid culture
Kafka, M.
Mayr, F.
Temml, V.
Möller, G.
Adamski, J.
Höfer, J.
Schwaiger, S.
Heidegger, I.
Matuszczak, B.
Schuster, D.
Klocker, H.
Bektic, J.
Stuppner, H.
Eder, I.E.
Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer
description 10.3390/cancers12082092
author2 BIOCHEMISTRY
author_facet BIOCHEMISTRY
Kafka, M.
Mayr, F.
Temml, V.
Möller, G.
Adamski, J.
Höfer, J.
Schwaiger, S.
Heidegger, I.
Matuszczak, B.
Schuster, D.
Klocker, H.
Bektic, J.
Stuppner, H.
Eder, I.E.
format Article
author Kafka, M.
Mayr, F.
Temml, V.
Möller, G.
Adamski, J.
Höfer, J.
Schwaiger, S.
Heidegger, I.
Matuszczak, B.
Schuster, D.
Klocker, H.
Bektic, J.
Stuppner, H.
Eder, I.E.
author_sort Kafka, M.
title Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer
title_short Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer
title_full Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer
title_fullStr Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer
title_full_unstemmed Dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant AR-V7 in enzalutamide resistant metastatic castration resistant prostate cancer
title_sort dual inhibitory action of a novel akr1c3 inhibitor on both full-length ar and the variant ar-v7 in enzalutamide resistant metastatic castration resistant prostate cancer
publisher MDPI AG
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/199759
_version_ 1800915003153317888